Etiopathogenesis of systemic lupus erythematosus: A 2014 update

被引:7
|
作者
Mathian, A. [1 ,2 ,3 ]
Arnaud, L. [1 ,2 ,3 ]
Amoura, Z. [1 ,2 ,3 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Interne 2, Ctr Natl Reference Lupus Syst & Syndrome Antiphol, F-75651 Paris, France
[2] Univ Paris 06, INSERM, UMR S 945, F-75013 Paris, France
[3] Univ Paris 06, F-75005 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2014年 / 35卷 / 08期
关键词
Systemic lupus erythematosus; Etiopathogenesis; B-lymphocyte; alpha-interferon; BLys; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; ACTIVATE B-CELLS; I INTERFERON; ANTIPHOSPHOLIPID SYNDROME; IFN-ALPHA; EXPRESSION SIGNATURE; MEDIATED RESPONSE; IMMUNE-COMPLEXES; APOPTOTIC CELLS;
D O I
10.1016/j.revmed.2013.10.334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematous is a chronic autoimmune disease characterized by the inflammation of several tissues and the production of auto-antibodies directed against nuclear antigens. Complex genetic disorders and environmental factors are at the origin of the disease but the precise cause of the autoimmune process is still unknown. Both innate and adaptive immune systems are involved. Apoptosis seems to be the main source of auto-antigens. The interactions between apoptotic cells, dendritic cells and lymphocytes activate the production of pathogenic antibodies and T lymphocytes. Amplification loops sustain the auto-immune process and the chronic inflammation. Several data point out B-lymphocytes and several cytokines involved in their homeostasis as new promising therapeutic targets. (C) 2013 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:503 / 511
页数:9
相关论文
共 50 条
  • [31] An Update on Pathogenesis of Systemic Lupus Erythematosus
    Ahmadpoor, Pedram
    Dalili, Nooshin
    Rostami, Mehrdad
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2014, 8 (03) : 171 - 184
  • [32] An update on autoantibodies in systemic lupus erythematosus
    Gomez-Banuelos, Eduardo
    Fava, Andrea
    Andrade, Felipe
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (02) : 61 - 67
  • [33] Update:: Treatment of systemic lupus erythematosus
    Alarcón-Segovia, D
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (02): : 219 - 222
  • [34] Update on antimalarials and systemic lupus erythematosus
    Ruiz-Irastorza, Guillermo
    Martin-Iglesias, Daniel
    Soto-Peleteiro, Adriana
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (06) : 572 - 582
  • [35] Update on cyclophosphamide for systemic lupus erythematosus
    Ortmann, RA
    Klippel, JH
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2000, 26 (02) : 363 - +
  • [36] Systemic lupus erythematosus: a clinical update
    Connelly, Kathryn
    Morand, Eric F.
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 (08) : 1219 - 1228
  • [37] Systemic lupus erythematosus - 2006 update
    Petri, M
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2006, 12 (01) : 37 - 40
  • [38] An update on the genetics of systemic lupus erythematosus
    Oparina, Nina
    Martinez-Bueno, Manuel
    Alarcon-Riquelme, Marta E.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (06) : 659 - 668
  • [39] Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus
    Rizwan Ahmad
    Haseeb Ahsan
    [J]. Clinical and Experimental Medicine, 2014, 14 : 1 - 11
  • [40] Cardiovascular disease in systemic lupus erythematosus: an update
    Liu, Yudong
    Kaplan, Mariana J.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 441 - 448